Microbot Medical's long-term debt is $550K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), MBOT shows a long-term debt of $550K. That compares with $47K in the prior-year period — up 1070.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MBOT's long-term debt is now $550K (was $47K) — a 1070.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Microbot Medical is outperforming or lagging.
Tracking MBOT's long-term debt over time shows whether Microbot Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $550K That compares with $47K in the prior-year period — up 1070.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Microbot Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $550K) with ownership activity and broader fundamentals.
Microbot Medical's long-term debt is $550K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.